Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
1,028.67
1,092.51
1,197.92
1,231.21
1,035.46
760.18
995.67
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,028.67
1,092.51
1,197.92
1,231.21
1,035.46
760.18
995.67
Raw Material Cost
488.44
526.18
515.24
525.77
500.00
406.33
400.57
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
224.71
225.54
227.14
211.52
176.35
201.21
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.91
1.48
3.25
0.63
0.20
0.32
1.12
Selling and Distribution Expenses
343.34
383.92
382.98
389.67
381.98
334.47
390.15
Other Expenses
4.70
-18.27
-18.47
-19.26
-17.68
-15.10
-17.61
Total Expenditure (Excl Depreciation)
880.70
953.62
942.30
950.57
916.85
766.50
816.93
Operating Profit (PBDIT) excl Other Income
148
138.9
255.6
280.59999999999997
118.6
-6.3
178.70000000000002
Other Income
22.46
16.82
23.26
31.92
7.92
12.15
19.53
Operating Profit (PBDIT)
264.10
247.99
363.99
399.49
211.32
92.81
269.39
Interest
1.91
1.48
3.25
0.63
0.20
0.32
1.12
Exceptional Items
6.95
-0.31
-68.56
0.46
-18.50
-665.29
-21.51
Gross Profit (PBDT)
540.24
566.33
682.68
705.45
535.47
353.85
595.10
Depreciation
105.28
106.51
96.55
94.68
88.36
88.38
86.17
Profit Before Tax
163.87
139.68
195.63
304.64
104.26
-661.18
160.58
Tax
24.15
34.10
56.31
77.49
27.43
19.38
34.19
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
131.62
91.76
126.20
218.79
66.48
-687.66
120.33
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
131.62
91.76
126.20
218.79
66.48
-687.66
120.33
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-3.00
-3.20
-5.49
-5.74
-0.38
3.19
5.53
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
128.62
88.56
120.71
213.05
66.10
-684.47
125.87
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,551.90
2,448.00
2,400.43
2,274.23
2,083.75
2,017.27
2,732.50
Earnings per share (EPS)
0.33
0.23
0.31
0.54
0.17
-1.71
0.3
Diluted Earnings per share
0.33
0.23
0.31
0.54
0.17
-1.71
0.3
Operating Profit Margin (Excl OI)
13.26%
11.41%
20.38%
22.16%
11.11%
-1.02%
16.44%
Gross Profit Margin
26.16%
22.53%
24.39%
32.43%
18.6%
-75.35%
24.78%
PAT Margin
12.8%
8.4%
10.53%
17.77%
6.42%
-90.46%
12.09%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is -5.84% vs -8.80% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 45.15% vs -26.59% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 4.50% vs -32.14% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 26.67% vs -54.55% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Sichuan Goldstone Asia Pharmaceutical, Inc. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
1,028.67
0
1,028.67
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,028.67
0
1,028.67
Raw Material Cost
488.44
0
488.44
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
1.91
0
1.91
Selling and Distribution Expenses
343.34
0
343.34
Other Expenses
4.70
0.00
4.70
Total Expenditure (Excl Depreciation)
880.70
0
880.70
Operating Profit (PBDIT) excl Other Income
147.98
0.00
147.98
Other Income
22.46
0
22.46
Operating Profit (PBDIT)
264.10
0
264.10
Interest
1.91
0
1.91
Exceptional Items
6.95
0
6.95
Gross Profit (PBDT)
540.24
0
540.24
Depreciation
105.28
0
105.28
Profit Before Tax
163.87
0
163.87
Tax
24.15
0
24.15
Provisions and contingencies
0
0
0.00
Profit After Tax
131.62
0
131.62
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
131.62
0
131.62
Share in Profit of Associates
0
0
0.00
Minority Interest
-3.00
0
-3.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
128.62
0
128.62
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,551.90
0
2,551.90
Earnings per share (EPS)
0.33
0
0.33
Diluted Earnings per share
0.33
0
0.33
Operating Profit Margin (Excl OI)
13.26%
0%
0.00
13.26%
Gross Profit Margin
26.16%
0%
0.00
26.16%
PAT Margin
12.80%
0%
0.00
12.80%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 102.87 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -5.84% vs -8.80% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 12.86 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 45.15% vs -26.59% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 24.16 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 4.50% vs -32.14% in Dec 2024
Annual - Interest
Interest 0.19 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 26.67% vs -54.55% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.26%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






